GeneOne Life Science Inc (011000) — Capital Reinvestment Ratio

Latest as of December 2021: 9.66x

GeneOne Life Science Inc (011000) has a Capital Reinvestment Ratio of 9.66x as of December 2021, meaning it reinvests 10% of its operating cash flow (₩3.67 Billion) in capital expenditures (₩35.40 Billion). See 011000 equity financing ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

9.66x
Capex / Operating Cash Flow

Operating Cash Flow

₩3.67 Billion
KRW

Capital Expenditures

₩35.40 Billion
KRW

Data as of

Dec 2021
Most recent filing

GeneOne Life Science Inc Capital Reinvestment Ratio (2015–2015)

This chart tracks GeneOne Life Science Inc's Capital Reinvestment Ratio across 1 annual periods. Check 011000 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for GeneOne Life Science Inc (2015–2015)

Year-by-year Capital Reinvestment Ratio for GeneOne Life Science Inc from 2015 to 2015. For live market cap and broader valuation context, see how much is GeneOne Life Science Inc worth.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2015 2.62x ₩778.50 Million ₩2.04 Billion
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow